- Home
- Personal stories
Personal stories
Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way
The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
By the numbers: Who gets lung cancer?
Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
It takes a village
Message from Dana Deardorff - November 2023 J&J Impact Ventures Newsletter
Improving community-based primary medical services to protect the health of China’s aging population
Community doctors are very important in the early prevention and treatment of diseases common in the elderly, such as atrial fibrillation and cataracts.
A tireless advocate for integrating community health workers into Kenya’s primary care system
Sheringham Odhiambo is fighting for the professionalization of community health workers in pursuit of a stronger, more resilient and equitable healthcare system that leaves no one behind.
To improve quality of care at her hospital, this doctor prioritizes the well-being and resilience of her staff
Patients benefit when nurses are recognized, fulfilled and happy, says Brenda Acoltzi, a community doctor in one of Mexico’s public health facilities.
Quiz: How much do you know about psoriasis?
The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. Take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common autoimmune disease.
What it’s like when your baby has a rare blood disorder
A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
What you need to know about Johnson & Johnson’s 2023 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.